263 related articles for article (PubMed ID: 38126767)
21. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
Theodoulou NH; Bamborough P; Bannister AJ; Becher I; Bit RA; Che KH; Chung CW; Dittmann A; Drewes G; Drewry DH; Gordon L; Grandi P; Leveridge M; Lindon M; Michon AM; Molnar J; Robson SC; Tomkinson NC; Kouzarides T; Prinjha RK; Humphreys PG
J Med Chem; 2016 Feb; 59(4):1425-39. PubMed ID: 25856009
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9).
Basuroy T; Dreier M; Baum C; Blomquist T; Trumbly R; Filipp FV; de la Serna IL
Pigment Cell Melanoma Res; 2023 Jan; 36(1):19-32. PubMed ID: 36112085
[TBL] [Abstract][Full Text] [Related]
23. Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells.
Yang Q; Vafaei S; Falahati A; Khosh A; Bariani MV; Omran MM; Bai T; Siblini H; Ali M; He C; Boyer TG; Al-Hendy A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255982
[TBL] [Abstract][Full Text] [Related]
24. Differential Contributions of mSWI/SNF Chromatin Remodeler Sub-Families to Myoblast Differentiation.
Padilla-Benavides T; Olea-Flores M; Sharma T; Syed SA; Witwicka H; Zuñiga-Eulogio MD; Zhang K; Navarro-Tito N; Imbalzano AN
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511016
[TBL] [Abstract][Full Text] [Related]
25. A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells.
Gatchalian J; Malik S; Ho J; Lee DS; Kelso TWR; Shokhirev MN; Dixon JR; Hargreaves DC
Nat Commun; 2018 Dec; 9(1):5139. PubMed ID: 30510198
[TBL] [Abstract][Full Text] [Related]
26. ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver.
Kurosawa K; Nakano M; Yokoseki I; Nagaoka M; Takemoto S; Sakai Y; Kobayashi K; Kazuki Y; Fukami T; Nakajima M
Biochem Pharmacol; 2023 Sep; 215():115733. PubMed ID: 37543347
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance.
Crawford TD; Vartanian S; Côté A; Bellon S; Duplessis M; Flynn EM; Hewitt M; Huang HR; Kiefer JR; Murray J; Nasveschuk CG; Pardo E; Romero FA; Sandy P; Tang Y; Taylor AM; Tsui V; Wang J; Wang S; Zawadzke L; Albrecht BK; Magnuson SR; Cochran AG; Stokoe D
Bioorg Med Chem Lett; 2017 Aug; 27(15):3534-3541. PubMed ID: 28606761
[TBL] [Abstract][Full Text] [Related]
28. BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia.
Sang X; Zhang Y; Fang F; Gao L; Tao Y; Li X; Zhang Z; Wang J; Tian Y; Li Z; Yao D; Wu Y; Chu X; Zhang K; Ma L; Lu L; Chen Y; Yu J; Zhuo R; Wu S; Zhang Z; Pan J; Hu S
J Immunol Res; 2022; 2022():7912484. PubMed ID: 35958877
[TBL] [Abstract][Full Text] [Related]
29. BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors.
Mu J; Sun X; Zhao Z; Sun H; Sun P
Cell Death Dis; 2021 Oct; 12(11):962. PubMed ID: 34667163
[TBL] [Abstract][Full Text] [Related]
30. Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.
Lou W; Gao K; Xu C; Li Q
IUBMB Life; 2021 Nov; 73(11):1334-1347. PubMed ID: 34415102
[TBL] [Abstract][Full Text] [Related]
31. [Understanding and therapeutic targeting of aberrant mRNA splicing mechanisms in oncogenesis].
Tanaka A; Kobayashi S; Xiao M; Inoue D
Rinsho Ketsueki; 2020; 61(6):643-650. PubMed ID: 32624538
[TBL] [Abstract][Full Text] [Related]
32. An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions.
Radzisheuskaya A; Peña-Rømer I; Lorenzini E; Koche R; Zhan Y; Shliaha PV; Cooper AJ; Fan Z; Shlyueva D; Johansen JV; Hendrickson RC; Helin K
EMBO J; 2023 Dec; 42(24):e114221. PubMed ID: 37987160
[TBL] [Abstract][Full Text] [Related]
33. Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia.
Baragaño Raneros A; Rodriguez RM; Bernardo Flórez A; Palomo P; Colado E; Minguela A; Suárez Álvarez B; López-Larrea C
Oncoimmunology; 2021 Mar; 10(1):1897294. PubMed ID: 33796404
[TBL] [Abstract][Full Text] [Related]
34. Differential requirements for different subfamilies of the mammalian SWI/SNF chromatin remodeling enzymes in myoblast cell cycle progression and expression of the Pax7 regulator.
Padilla-Benavides T; Olea-Flores M; Nshanji Y; Maung MT; Syed SA; Imbalzano AN
Biochim Biophys Acta Gene Regul Mech; 2022 Feb; 1865(2):194801. PubMed ID: 35217218
[TBL] [Abstract][Full Text] [Related]
35.
Bell CM; Raffeiner P; Hart JR; Vogt PK
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31652979
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of imidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD9 inhibitors.
Zheng P; Zhang J; Ma H; Yuan X; Chen P; Zhou J; Zhang H
Bioorg Med Chem; 2019 Apr; 27(7):1391-1404. PubMed ID: 30824168
[TBL] [Abstract][Full Text] [Related]
37. Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway.
Dou C; Sun L; Wang L; Cheng J; Wu W; Zhang C; Xu Q; Tu K; Liu J
Cell Death Dis; 2020 Sep; 11(9):730. PubMed ID: 32908135
[TBL] [Abstract][Full Text] [Related]
38. SMARCE1 deficiency generates a targetable mSWI/SNF dependency in clear cell meningioma.
St Pierre R; Collings CK; Samé Guerra DD; Widmer CJ; Bolonduro O; Mashtalir N; Sankar A; Liang Y; Bi WL; Gerkes EH; Ramesh V; Qi J; Smith MJ; Meredith DM; Kadoch C
Nat Genet; 2022 Jun; 54(6):861-873. PubMed ID: 35681054
[TBL] [Abstract][Full Text] [Related]
39. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.
Zuber J; Shi J; Wang E; Rappaport AR; Herrmann H; Sison EA; Magoon D; Qi J; Blatt K; Wunderlich M; Taylor MJ; Johns C; Chicas A; Mulloy JC; Kogan SC; Brown P; Valent P; Bradner JE; Lowe SW; Vakoc CR
Nature; 2011 Aug; 478(7370):524-8. PubMed ID: 21814200
[TBL] [Abstract][Full Text] [Related]
40. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
Alpsoy A; Dykhuizen EC
J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
